Managing intravitreal injections in adults in COVID-19 and post-COVID-19 era- Initial experiences

Indian J Ophthalmol. 2020 Jun;68(6):1216-1218. doi: 10.4103/ijo.IJO_1391_20.

Authors

Divya Agarwal¹, Atul Kumar¹

Affiliation

¹ Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.

No abstract available

Publication types

Letter

MeSH terms

Adult
Angiogenesis Inhibitors / administration & dosage*
Betacoronavirus*
COVID-19
Coronavirus Infections / epidemiology
Coronavirus Infections / prevention & control*
Cross Infection / prevention & control
Disease Transmission, Infectious / prevention & control
Humans
Infection Control / methods*
Intravitreal Injections
Pandemics / prevention & control*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / prevention & control*
Practice Guidelines as Topic
Retinal Diseases / drug therapy*
SARS-CoV-2
Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

Angiogenesis Inhibitors
VEGFA protein, human
Vascular Endothelial Growth Factor A